Global Coronary Stents Market: Size, Trends & Forecasts (2019-2023)
SCOPE OF THE REPORT
The report titled “Global Coronary Stents Market: Size, Trends & Forecasts (2019-2023)” provides analysis of the coronary stents market with detailed analysis of the market size by value and segments. The report also includes the analysis of the market for regions such as North America, Europe and Asia Pacific. An overall analysis of the global coronary artery treatment devices market has also been included in the report in order to the show the position of the coronary stents category in comparison with the overall market.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall coronary stents market has also been forecasted for the years 2019-2023, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Abbott Laboratories, Medtronic Plc, B. Braun Melsungen AG, Boston Scientific Corporation and MicroPort Scientific Corporation are some of the leading players operating in the global coronary stents market whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Company Coverage
Cardiovascular disease (CVD) is a term that is used for describing conditions that have a direct negative effect on the functioning of the heart. Coronary artery diseases (CAD) is a major sub group of CVD. CAD is caused by the build up of fatty deposits on the walls of the arteries and may further develop into acute myocardial infract (also known as Heart Attack). Percutaneous Transluminal Coronary Angioplasty (PTCA) balloon catheters, coronary guidewires and coronary stents are the devices that play a vital part in the treatment of CAD.
Coronary stent is a small mesh tube that holds the arteries and lowers the risks of the arteries re- narrowing. Thereby, lowering the risk of heart attack.
The global coronary stents market is split on the basis of product type, deployment and end user. On the basis of product type, the market can be further split into Drug Eluting Coronary Stents, Bare Metal Coronary Stents and Bioresorbable Coronary Stents. On the basis of deployment, the market is bifurcated into Balloon Expandable Coronary Stents and Self Expandable Coronary Stents. On the basis of end users, the market is split into hospitals, specialty clinics and ambulatory surgical centers.
The global coronary stents market is forecasted to grow at a healthy rate during the forecast period (2019-2023). The market is supported by various growth drivers such as rise in geriatric population, increase in diabetic population, rising prevalence of obesity, lack of physical activity and rapidly changing lifestyle. High cost of coronary stents and the stringent approval process to make these stents available for commercial use are some of the tough challenges faced by the market.
The report titled “Global Coronary Stents Market: Size, Trends & Forecasts (2019-2023)” provides analysis of the coronary stents market with detailed analysis of the market size by value and segments. The report also includes the analysis of the market for regions such as North America, Europe and Asia Pacific. An overall analysis of the global coronary artery treatment devices market has also been included in the report in order to the show the position of the coronary stents category in comparison with the overall market.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall coronary stents market has also been forecasted for the years 2019-2023, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Abbott Laboratories, Medtronic Plc, B. Braun Melsungen AG, Boston Scientific Corporation and MicroPort Scientific Corporation are some of the leading players operating in the global coronary stents market whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Company Coverage
- Abbott Laboratories
- Medtronic Plc
- B. Braun Melsungen AG
- Boston Scientific Corporation
- MicroPort Scientific Corporation
- North America
- Europe
- Asia Pacific
Cardiovascular disease (CVD) is a term that is used for describing conditions that have a direct negative effect on the functioning of the heart. Coronary artery diseases (CAD) is a major sub group of CVD. CAD is caused by the build up of fatty deposits on the walls of the arteries and may further develop into acute myocardial infract (also known as Heart Attack). Percutaneous Transluminal Coronary Angioplasty (PTCA) balloon catheters, coronary guidewires and coronary stents are the devices that play a vital part in the treatment of CAD.
Coronary stent is a small mesh tube that holds the arteries and lowers the risks of the arteries re- narrowing. Thereby, lowering the risk of heart attack.
The global coronary stents market is split on the basis of product type, deployment and end user. On the basis of product type, the market can be further split into Drug Eluting Coronary Stents, Bare Metal Coronary Stents and Bioresorbable Coronary Stents. On the basis of deployment, the market is bifurcated into Balloon Expandable Coronary Stents and Self Expandable Coronary Stents. On the basis of end users, the market is split into hospitals, specialty clinics and ambulatory surgical centers.
The global coronary stents market is forecasted to grow at a healthy rate during the forecast period (2019-2023). The market is supported by various growth drivers such as rise in geriatric population, increase in diabetic population, rising prevalence of obesity, lack of physical activity and rapidly changing lifestyle. High cost of coronary stents and the stringent approval process to make these stents available for commercial use are some of the tough challenges faced by the market.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Cardiovascular Diseases (CVD): An Overview
2.2 Types of CVD: An Overview
2.3 Coronary Artery Diseases (CAD) Treatment Devices: An Overview
2.4 Development of Coronary Stents by Generation
2.5 Global Coronary Stents Market: An Overview
3. GLOBAL MARKET ANALYSIS
3.1 Global Coronary Artery Diseases (CAD) Treatment Device Market: An Analysis
3.1.1 Global Coronary Artery Diseases (CAD) Treatment Devices Market by Value
3.1.2 Global Coronary Artery Diseases (CAD) Treatment Devices Market by Product Type (Coronary Stents and Others)
3.2 Global Coronary Stents Market: An Analysis
3.2.1 Global Coronary Stents Market by Value
3.2.2 Global Coronary Stents Market by Product Type
3.2.3 Global Drug Eluting Coronary Stents Market by Value
3.2.4 Global Bare Metal Coronary Stent Market by Value
3.2.5 Global Bioresorbable Coronary Stents Market by Value
3.3 Global Coronary Stents Market: Regional Analysis (North America, Europe, Asia Pacific and Rest of the World)
4. REGIONAL ANALYSIS
4.1 North America Coronary Stents Market: An Analysis
4.1.1 North America Coronary Stents Market by Value
4.2 Europe Coronary Stents Market: An Analysis
4.2.1 Europe Coronary Stents Market by Value
4.3 Asia Pacific Coronary Stents Market: An Analysis
4.3.1 Asia Pacific Coronary Stents Market by Value
4.3.2 Asia Pacific Coronary Stents Market by Countries (China and Rest of Asia Pacific)
4.3.3 China Coronary Stents Market by Value
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Rising Diabetic Population
5.1.2 Increasing Geriatric Population
5.1.3 Rising Prevalence of Obesity
5.1.4 Lack of Physical Activity
5.1.5 Rapidly Changing Lifestyle
5.2 Challenges
5.2.1 High Cost of Coronary Stents
5.2.2 Stringent Approval Process
5.3 Market Trends
5.3.1 Product Launches
5.3.2 Future Prospects of Bioresorbable Coronary Stents
5.3.3 Mergers and Acquisitions
5.3.4 Technological Advancements
6.COMPETITIVE LANDSCAPE
6.1 Global Coronary Stents Market Players Comparison
7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Medtronic Plc
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 B. Braun Melsungen AG
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 Boston Scientific Corporation
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
7.5 MicroPort Scientific Corporation
7.5.1 Business Overview
7.5.2 Financial Overview
7.5.3 Business Strategy
2. INTRODUCTION
2.1 Cardiovascular Diseases (CVD): An Overview
2.2 Types of CVD: An Overview
2.3 Coronary Artery Diseases (CAD) Treatment Devices: An Overview
2.4 Development of Coronary Stents by Generation
2.5 Global Coronary Stents Market: An Overview
3. GLOBAL MARKET ANALYSIS
3.1 Global Coronary Artery Diseases (CAD) Treatment Device Market: An Analysis
3.1.1 Global Coronary Artery Diseases (CAD) Treatment Devices Market by Value
3.1.2 Global Coronary Artery Diseases (CAD) Treatment Devices Market by Product Type (Coronary Stents and Others)
3.2 Global Coronary Stents Market: An Analysis
3.2.1 Global Coronary Stents Market by Value
3.2.2 Global Coronary Stents Market by Product Type
3.2.3 Global Drug Eluting Coronary Stents Market by Value
3.2.4 Global Bare Metal Coronary Stent Market by Value
3.2.5 Global Bioresorbable Coronary Stents Market by Value
3.3 Global Coronary Stents Market: Regional Analysis (North America, Europe, Asia Pacific and Rest of the World)
4. REGIONAL ANALYSIS
4.1 North America Coronary Stents Market: An Analysis
4.1.1 North America Coronary Stents Market by Value
4.2 Europe Coronary Stents Market: An Analysis
4.2.1 Europe Coronary Stents Market by Value
4.3 Asia Pacific Coronary Stents Market: An Analysis
4.3.1 Asia Pacific Coronary Stents Market by Value
4.3.2 Asia Pacific Coronary Stents Market by Countries (China and Rest of Asia Pacific)
4.3.3 China Coronary Stents Market by Value
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Rising Diabetic Population
5.1.2 Increasing Geriatric Population
5.1.3 Rising Prevalence of Obesity
5.1.4 Lack of Physical Activity
5.1.5 Rapidly Changing Lifestyle
5.2 Challenges
5.2.1 High Cost of Coronary Stents
5.2.2 Stringent Approval Process
5.3 Market Trends
5.3.1 Product Launches
5.3.2 Future Prospects of Bioresorbable Coronary Stents
5.3.3 Mergers and Acquisitions
5.3.4 Technological Advancements
6.COMPETITIVE LANDSCAPE
6.1 Global Coronary Stents Market Players Comparison
7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Medtronic Plc
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 B. Braun Melsungen AG
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 Boston Scientific Corporation
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
7.5 MicroPort Scientific Corporation
7.5.1 Business Overview
7.5.2 Financial Overview
7.5.3 Business Strategy
LIST OF FIGURES
Figure 1: Global Coronary Stents Market Segments
Figure 2: Global CAD Treatment Devices Market by Value; 2016-2018 (US$ Billion)
Figure 3: Global CAD Treatment Devices Market by Value; 2019-2023 (US$ Billion)
Figure 4: Global CAD Treatment Device Market by Product Type; 2018 (Percentage,%)
Figure 5: Global Coronary Stents Market by Value; 2016-2018 (US$ Billion)
Figure 6: Global Coronary Stents Market by Value; 2019-2023 (US$ Billion)
Figure 7: Global Coronary Stents Market by Product Type; 2018 (Percentage,%)
Figure 8: Global Drug Eluting Coronary Stents Market by Value; 2016-2018 (US$ Billion)
Figure 9: Global Drug Eluting Coronary Stents Market by Value; 2019-2023 (US$ Billion)
Figure 10: Global Bare Metal Coronary Stents Market by Value; 2016-2018 (US$ Billion)
Figure 11: Global Bare Metal Coronary Stents Market by Value; 2019-2023 (US$ Billion)
Figure 12: Global Bioresorbable Coronary Stents Market by Value; 2016-2018 (US$ Million)
Figure 13: Global Bioresorbable Coronary Stents Market by Value; 2019-2023 (US$ Million)
Figure 14: Global Coronary Stents Market by Region; 2018 (Percentage,%)
Figure 15: North America Coronary Stents Market by Value; 2018-2023 (US$ Billion)
Figure 16: Europe Coronary Stents Market by Value; 2018-2023 (US$ Billion)
Figure 17: Asia Pacific Coronary Stents Market by Value; 2018-2023 (US$ Billion)
Figure 18: Asia Pacific Coronary Stents Market by Countries; 2018 (Percentage,%)
Figure 19: China Coronary Stents Market by Value; 2018-2023 (US$ Billion)
Figure 20: Global Diabetic Population; 2011-2040 (Million)
Figure 21: Population Above the Age of 60 Years Globally; 2012-2017 (Million)
Figure 22: Prevalence of obesity among adults in the US in 2012 and 2030 (Percentage,%)
Figure 23: Abbott Laboratories Net Sales; 2014-2018 (US$ Billion)
Figure 24: Abbott Laboratories Net Sales by Segments; 2018 (Percentage,%)
Figure 25: Medtronic Plc Net Sales; 2014-2018 (US$ Billion)
Figure 26: Medtronic plc Net Sales by Segments; 2018 (Percentage, %)
Figure 27: Medtronic plc Net Sales by Region; 2018 (Percentage, %)
Figure 28: B. Braun Melsungen Sales; 2014-2018 (US$ Billion)
Figure 29: B.Braun Melsungen Sales by Division; 2018 (Percentage, %)
Figure 30: Boston Scientific Corporation Net Sales; 2014-2018 (US$ Billion)
Figure 31: Boston Scientific Corporation Net Sales by Segments; 2018 (Percentage, %)
Figure 32: MicroPort Scientific Corporation Revenues; 2014-2018(US$ Million)
Figure 33: MicroPort Scientific Corporation Revenue by Segments; 2018 (Percentage, %)
Table 1: Types of Cardiovascular Diseases (CVD)
Table 2: Development of Coronary Stents by Generation
Table 3: Coronary Stent Market by Product Type
Table 4: Coronary Stent Market by Type of Deployment
Table 5: Coronary Stents Players Comparison
Figure 1: Global Coronary Stents Market Segments
Figure 2: Global CAD Treatment Devices Market by Value; 2016-2018 (US$ Billion)
Figure 3: Global CAD Treatment Devices Market by Value; 2019-2023 (US$ Billion)
Figure 4: Global CAD Treatment Device Market by Product Type; 2018 (Percentage,%)
Figure 5: Global Coronary Stents Market by Value; 2016-2018 (US$ Billion)
Figure 6: Global Coronary Stents Market by Value; 2019-2023 (US$ Billion)
Figure 7: Global Coronary Stents Market by Product Type; 2018 (Percentage,%)
Figure 8: Global Drug Eluting Coronary Stents Market by Value; 2016-2018 (US$ Billion)
Figure 9: Global Drug Eluting Coronary Stents Market by Value; 2019-2023 (US$ Billion)
Figure 10: Global Bare Metal Coronary Stents Market by Value; 2016-2018 (US$ Billion)
Figure 11: Global Bare Metal Coronary Stents Market by Value; 2019-2023 (US$ Billion)
Figure 12: Global Bioresorbable Coronary Stents Market by Value; 2016-2018 (US$ Million)
Figure 13: Global Bioresorbable Coronary Stents Market by Value; 2019-2023 (US$ Million)
Figure 14: Global Coronary Stents Market by Region; 2018 (Percentage,%)
Figure 15: North America Coronary Stents Market by Value; 2018-2023 (US$ Billion)
Figure 16: Europe Coronary Stents Market by Value; 2018-2023 (US$ Billion)
Figure 17: Asia Pacific Coronary Stents Market by Value; 2018-2023 (US$ Billion)
Figure 18: Asia Pacific Coronary Stents Market by Countries; 2018 (Percentage,%)
Figure 19: China Coronary Stents Market by Value; 2018-2023 (US$ Billion)
Figure 20: Global Diabetic Population; 2011-2040 (Million)
Figure 21: Population Above the Age of 60 Years Globally; 2012-2017 (Million)
Figure 22: Prevalence of obesity among adults in the US in 2012 and 2030 (Percentage,%)
Figure 23: Abbott Laboratories Net Sales; 2014-2018 (US$ Billion)
Figure 24: Abbott Laboratories Net Sales by Segments; 2018 (Percentage,%)
Figure 25: Medtronic Plc Net Sales; 2014-2018 (US$ Billion)
Figure 26: Medtronic plc Net Sales by Segments; 2018 (Percentage, %)
Figure 27: Medtronic plc Net Sales by Region; 2018 (Percentage, %)
Figure 28: B. Braun Melsungen Sales; 2014-2018 (US$ Billion)
Figure 29: B.Braun Melsungen Sales by Division; 2018 (Percentage, %)
Figure 30: Boston Scientific Corporation Net Sales; 2014-2018 (US$ Billion)
Figure 31: Boston Scientific Corporation Net Sales by Segments; 2018 (Percentage, %)
Figure 32: MicroPort Scientific Corporation Revenues; 2014-2018(US$ Million)
Figure 33: MicroPort Scientific Corporation Revenue by Segments; 2018 (Percentage, %)
Table 1: Types of Cardiovascular Diseases (CVD)
Table 2: Development of Coronary Stents by Generation
Table 3: Coronary Stent Market by Product Type
Table 4: Coronary Stent Market by Type of Deployment
Table 5: Coronary Stents Players Comparison
